Traphagen Investment Advisors LLC Pfizer Inc Transaction History

Traphagen Investment Advisors LLC

$820 Million
Q2 2025

A detailed history of Traphagen Investment Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 26,303 shares of PFE stock, worth $626,274. This represents 0.08% of its overall portfolio holdings.

Number of Shares

26,303

Previous 27,587 4.65%

Holding current value

$626,274

Previous $699,000 8.87%

% of portfolio

0.08%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$21.59 - $24.84 $27,721 - $31,894	-1,284 Reduced 4.65%	26,303 $637,000
Q1 2025 Apr 17, 2025	SELL	$25.01 - $27.13 $69,852 - $75,774	-2,793 Reduced 9.19%	27,587 $699,000
Q4 2024 Jan 17, 2025	SELL	$24.8 - $30.19 $71,696 - $87,279	-2,891 Reduced 8.69%	30,380 $805,000
Q3 2024 Oct 21, 2024	BUY	$27.7 - $31.39 $8,947 - $10,138	323 Added 0.98%	33,271 $962,000
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $2,879 - $3,374	-114 Reduced 0.34%	32,948 $921,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $855,975 - $982,933	33,062 New	33,062 $917 Million
Q4 2023 Jun 17, 2024	BUY	$26.13 - $33.94 $125,842 - $163,455	4,816 Added 14.57%	37,878 $1.09 Billion
Q3 2023 Jun 17, 2024	BUY	$32.09 - $37.51 $111,737 - $130,609	3,482 Added 10.53%	36,544 $1.21 Billion
Q2 2023 Jun 17, 2024	BUY	$36.12 - $41.79 $267,974 - $310,040	7,419 Added 22.44%	40,481 $1.48 Billion
Q1 2023 Jun 17, 2024	SELL	$39.39 - $51.28 $86,500 - $112,610	-2,196 Reduced 5.16%	40,332 $1.65 Billion
Q4 2022 Jun 17, 2024	BUY	$41.75 - $54.5 $395,205 - $515,897	9,466 Added 28.63%	42,528 $2.18 Billion
Q3 2022 Jun 17, 2024	SELL	$43.76 - $53.42 $5,601 - $6,837	-128 Reduced 0.3%	42,753 $1.87 Billion
Q2 2022 Jun 17, 2024	BUY	$46.53 - $55.17 $456,878 - $541,714	9,819 Added 29.7%	42,881 $2.25 Billion
Q1 2022 Jun 17, 2024	BUY	$45.75 - $56.69 $134,596 - $166,781	2,942 Added 7.81%	40,631 $2.1 Billion
Q4 2021 Jun 17, 2024	BUY	$41.32 - $61.25 $191,187 - $283,403	4,627 Added 13.99%	37,689 $2.23 Billion
Q3 2021 Jun 17, 2024	BUY	$39.25 - $50.42 $12,246 - $15,731	312 Added 0.86%	36,463 $1.57 Billion
Q2 2021 Jun 17, 2024	SELL	$35.91 - $40.68 $44,887 - $50,850	-1,250 Reduced 3.34%	36,151 $1.42 Billion
Q1 2021 Jun 17, 2024	BUY	$33.49 - $37.77 $145,313 - $163,884	4,339 Added 13.12%	37,401 $1.36 Billion
Q4 2020 Jun 17, 2024	SELL	$33.47 - $42.56 $121,897 - $155,003	-3,642 Reduced 8.83%	37,604 $1.38 Billion
Q3 2020 Jun 17, 2024	SELL	$31.75 - $37.25 $26,733 - $31,364	-842 Reduced 2.0%	41,246 $1.51 Billion
Q2 2020 Jun 17, 2024	BUY	$30.12 - $36.54 $271,863 - $329,810	9,026 Added 27.3%	42,088 $1.38 Billion
Q1 2020 Jun 17, 2024	BUY	$27.03 - $38.62 $277,057 - $395,855	10,250 Added 31.0%	43,312 $1.41 Billion
Q4 2019 Jun 17, 2024	BUY	$32.92 - $37.36 $249,961 - $283,674	7,593 Added 22.97%	40,655 $1.59 Billion
Q3 2019 Jun 17, 2024	BUY	$32.49 - $42.13 $8,674 - $11,248	267 Added 0.81%	33,329 $1.2 Billion
Q2 2019 Jun 17, 2024	SELL	$36.98 - $41.52 $117,078 - $131,452	-3,166 Reduced 9.58%	29,896 $1.3 Billion
Q1 2019 Jun 17, 2024	SELL	$37.5 - $41.2 $119,212 - $130,974	-3,179 Reduced 9.62%	29,883 $1.27 Billion

Others Institutions Holding PFE

# of Institutions

3,355

Shares Held

3.6B

Call Options Held

104M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $134B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Account

Traphagen Investment Advisors LLC Pfizer Inc Transaction History